In-silico evaluation of Malawi essential medicines and reactive metabolites for potential drug-induced toxicities
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
In-silico evaluation of Malawi essential medicines and reactive metabolites for potential drug-induced toxicities ; volume:22 ; number:1 ; day:16 ; month:6 ; year:2021 ; pages:1-10 ; date:12.2021
BMC pharmacology & toxicology ; 22, Heft 1 (16.6.2021), 1-10, 12.2021
- Urheber
-
Chikowe, Ibrahim
Phiri, Alfred Chipanda
Mbewe, Kirios Patrick
Matekenya, Dunstan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40360-021-00499-6
- URN
-
urn:nbn:de:101:1-2021101120263769695003
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chikowe, Ibrahim
- Phiri, Alfred Chipanda
- Mbewe, Kirios Patrick
- Matekenya, Dunstan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Post-marketing surveillance of anti-malarial medicines used in Malawi
Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
Drug-induced uveitis
Gastrointestinal toxicities of proteasome inhibitor therapy
Drug-induced neurological disorders
Drug-induced neurological disorders
Drug-Induced Cognitive Impairment
Differential toxicities of insecticides and halogenated aromatics
Malawi: Malawi-German Health Programme
Malawi
Malawi,
Malawi
Post-marketing surveillance of anti-malarial medicines used in Malawi
Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
Drug-induced uveitis
Gastrointestinal toxicities of proteasome inhibitor therapy
Drug-induced neurological disorders
Drug-induced neurological disorders
Drug-Induced Cognitive Impairment
Differential toxicities of insecticides and halogenated aromatics
Malawi: Malawi-German Health Programme
Malawi
Malawi,
Malawi
Post-marketing surveillance of anti-malarial medicines used in Malawi
Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
Drug-induced uveitis
Gastrointestinal toxicities of proteasome inhibitor therapy
Drug-induced neurological disorders
Drug-induced neurological disorders
Drug-Induced Cognitive Impairment
Differential toxicities of insecticides and halogenated aromatics
Malawi: Malawi-German Health Programme
Malawi
Malawi,